Results
1
Mid-Large Cap Stocks
1 companies
Lakefront Biotherapeutics
Market Cap: €1.7b
A biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.
LKFT
€25.70
7D
4.5%
1Y
7.4%
